Stay updated on Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.

Latest updates to the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded a new revision entry (Revision: v3.3.3) to the Record History. The HHS Vulnerability Disclosure footer was removed and the older Revision: v3.3.2 entry was deleted.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe Record History now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0 for the ClinicalTrials.gov record NCT04802876. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe updated version removed a funding-status notice banner, but the trial details and history remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check68 days agoChange DetectedDifference0.1%

- Check89 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference12%

- Check97 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Tislelizumab & Spartalizumab in PD1-high Clinical Trial page.